
    
      Patients were sub-divided into an AQP4 seropositive group and an AQP4 seronegative group,
      according to the results of the AQP4-Ab test. All patients with complete medical histories
      underwent routine neurological examinations, brain MRIs, and ophthalmological examinations,
      including best corrected visual acuity (BCVA), intraocular pressure, slit lamp and fundus
      examination, VF and VEP, laboratory testing, including blood routine, HIV HBV HCV Syphilis,
      mitochondrial DNA sequencing, and a profile of autoantibodies, including antinuclear antibody
      (ANA), extractable nuclear antigen antibodies (SSA/SSB), rheumatoid factor (RF),
      anticardiolipin antibodies (ACA), and antithyroglobulin antibody.
    
  